Article Sidebar

PDF
Date Published: 05/07/2023
Abstract Views: 216
Views PDF: 80
DOI: https://doi.org/10.51298/vmj.v527i2.5921
Issue
Vol. 527 No. 2 (2023)
Section
Các bài báo
How to Cite
Nguyễn, T. T., & Vương, S. T. (2023). SURVEYING THE RELATIONSHIP BETWEEN BLOOD CELLS, BONE MARROW AND STAGE IN PATENTS WITH MULTIPLE MYELOMA. Vietnam Medical Journal, 527(2). https://doi.org/10.51298/vmj.v527i2.5921

SURVEYING THE RELATIONSHIP BETWEEN BLOOD CELLS, BONE MARROW AND STAGE IN PATENTS WITH MULTIPLE MYELOMA

Tuấn Tùng Nguyễn1,, Sơn Thành Vương1
1 Bach Mai Hospital

Main Article Content

Abstract

Objectives: Assess each relationship between peripheral blood cells, bone marrow cytology, bone marrow histopathology and disease stage in patients with multiple myeloma at Bach Mai Hospital in 2016 - 2022. Subjects: 62 patients were diagnosed with Multiple myeloma according to the criteria of IMWG 2016. Methods: Cross-sectional desciption. Results and conclusion: Patients in the ISS III group had a higher rate of plasma cells in the blood than the ISS II and ISSI groups. The percentage of positive CD 20 on plasma cells of the ISS III group was 56.6%, 25.0% higher than that of the ISS II group and the ISS I group was 10.5%. No association was found about the positive rate of CD19, CD56, CD81, CD117 with ISS disease stage.

Article Details

Keywords

Multiple Myeloma, Bach Mai hospital

References

. Jenny Bird, Roger Owen, Shirley d’Sa, (2010). Guidelines on the diagnosis and management of multiple myeloma. British Committee for Standards in Haematology in conjunction with the UK Myeloma Forum, 13 - 15.
2. Kyle RA, Rajkumar S. Vincent (2008). Multiple myeloma. Blood. 111(6): 2962-2967.
3. Conté L G , Figueroa M G , Lois V V (2008). Prognostic value of the new international staging system in multiple myeloma. Comparison with Durie-Salmon staging system. Revista Medica de Chile 136(1):7-12
4. Mittelman M (2003). The implications of anemia in multiple myeloma. Clin Lymphoma. 4 Suppl 1:S23-9.
5. Ludwig H1, Pohl G, Osterborg A (2004). Anemia in multiple myeloma. Clin Adv Hematol Oncol. 2(4):233-41.
7. Gunnar Birgegård (2008). Managing anemia in lymphoma and multiple myeloma. Ther Clin Risk Manag. 4(2): 527-539.
8. Riccardi A, Gobbi PG, Ucci G (1991). Changing clinical presentation of multiple myeloma. Eur J Cancer. 27(11):1401-5.
9. Witzig TE, Gertz MA, Lust JA, Kyle RA, O'Fallon WM, Greipp PR (1996). Peripheral blood monoclonal plasma cells as a predictor of survival in patients with multiple myeloma. Blood 88: 1780-1787.
10. Witzig TE, Kyle RA, O'Fallon WM, Greipp PR (1994). Detection of peripheral blood plasma cells as a predictor of disease course in patients